Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yili Li

Showing results (51-60 of 52) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 52 results.
Journal of Immunology (Baltimore, Md. : 1950)|October 11, 2013
Structure-based design of altered MHC class II-restricted peptide ligands with heterogeneous immunogenicityShuming Chen, Yili Li, Florence R Depontieu, et al.
The AAPS Journal|February 12, 2026
Proceedings of the 2024 FDA-CRCG Workshop: Scientific and Regulatory Considerations for Assessment of Immunogenicity Risk for Generic Peptide and Oligonucleotide Drug ProductsJennifer K Lee, Ha-Na Lee, Sudhir Agrawal, et al.
Pageof 6

Showing results (51-60 of 52) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 52 results.
Journal of Immunology (Baltimore, Md. : 1950)|October 11, 2013
Structure-based design of altered MHC class II-restricted peptide ligands with heterogeneous immunogenicityShuming Chen, Yili Li, Florence R Depontieu, et al.
The AAPS Journal|February 12, 2026
Proceedings of the 2024 FDA-CRCG Workshop: Scientific and Regulatory Considerations for Assessment of Immunogenicity Risk for Generic Peptide and Oligonucleotide Drug ProductsJennifer K Lee, Ha-Na Lee, Sudhir Agrawal, et al.
Pageof 6